AICAR 身份指南：Acadesine、ZMP 和 AMPK 证据边界
AICAR naming often collapses acadesine, its intracellular phosphorylated metabolite ZMP and an entire AMPK pathway into one label. Reproducible research needs those…
阅读源码评论 →
Research Topic
代谢与身体成分
Incretin receptor agonists are among the most actively studied peptide classes in metabolic research. This group covers single, dual and triple receptor agonists alongside the amylin analogues and lipolytic sequences frequently used with them.
Catalog materials are presented for research use. Analytical methods and lot-document availability vary by material and must be confirmed from the applicable specification and records.
相关产品
货号
产品
规格
Topic knowledge
Source-reviewed reading for metabolic & body composition
Continue from catalog navigation into editorial analysis, evidence records and quality-documentation guidance.
Showing 1–6 of 16 reviewed articles · Page 1 of 3
AICAR 治疗糖尿病性多发性神经病：2024 小鼠研究发现了什么
A 2024 study reported prevention and reversal of neuropathy measures after experimental AICAR exposure in mouse models of type 1 and type…
阅读源码评论 →AOD-9604 证据边界：GH 片段生物学、失败的开发和批次标识
AOD-9604 is a modified growth-hormone fragment developed around a lipolysis hypothesis. Preclinical plausibility and early development do not override the larger null…
阅读源码评论 →AOD-9604 OPTIONS 研究：主要结果、无效结果和证据限制
AOD-9604 progressed beyond animal work into an obesity-development program. FDA’s 2024 review records that the large OPTIONS study did not show statistically…
阅读源码评论 →MOTS-c“人类”：标签的含义以及 FDA 所说的内容仍然缺失
“Human” in a MOTS-c catalog title ordinarily describes the referenced peptide sequence; it does not mean the material was isolated from a…
阅读源码评论 →2015 细胞代谢论文中的 MOTS-c：细胞、小鼠和人类证据差距
The paper that introduced MOTS-c combined cell experiments with mouse metabolic models. It is an important discovery record, but the intervention findings…
阅读源码评论 →Need a peptide for metabolic & body composition research?
If a target is not listed, submit the sequence, scale and specification for a custom-project feasibility review.